Gut health plays a key role in overall health and with an estimated 30 million Americans suffering from IBS, Gut Health Awareness is more important than ever.
Digestive complaints can be embarrassing but having important conversations about gut health is critical because help is available for those suffering with chronic and uncomfortable symptoms.
In a study that evaluated 2,256 records of patients suffering from IBS-related symptoms and who had fecal biomarker testing, 82.8% included at least one abnormal value.1 Once abnormal values are identified, targeted treatment and key gut alterations that may resolve symptoms can be put into action so healing can begin.
GI Effects® Stool Profiles looks at the microbiome and analyzes fecal biomarkers for a complete gut health assessment. It is an important diagnostic starting place and a pivotal tool when working to optimize gut heath.
We hope the short video encourages you to raise awareness about gut health…because good health begins in the gut.
1 - Julius Goepp, MD; Elizabeth Fowler, PhD, Teresa McBride, ND, Darry Landis, MD, "Frequency of Abnormal Fecal Biomarkers in Irritable Bowel Syndrome" in Global Advances in Health and Medicine, ed. May 2014, Vol. 3., No. 3.
Lydia Coutre. Modern Healthcare, "Cleveland Clinic Announces top 10 medical innovations for 2017". 10/27/16.
Brian W. Ward; Jeannine S. Schiller, MPH; Richard A. Goodman, MD, MPH CDC, "Multiple Chronic Conditions Among US Adults: A 2012 Update" Centers for Disease Control and Protection
Brandt, LJ, Chey WD, Foxx-Orenstein AE Et. Al. An evidence-based position statement on the management of irritable bowel syndrome Am. J Gastroenterol. 2009;104 Suppl 1:S1 35
The following products may be of interest to you!
The GI Effects Stool Profile is an advanced stool test that provides immediate, actionable clinical information for the management of gut health.
The GI Effects Microbial Ecology Profile is the preferred stool test for the evaluation and identification of bacteria and parasites.
The Comprehensive Digestive Stool Analysis 2.0™ (CDSA 2.0) offers unique insight into overall gastrointestinal health by assessing advanced biomarkers.